(Q45869806)

17 December 2017

title

Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1. (English)

1 reference

17 December 2017

7

B Roizman

1 reference

17 December 2017

author name string

S J Advani

1

1 reference

17 December 2017

J M Markert

2

1 reference

17 December 2017

R F Sood

3

1 reference

17 December 2017

S Samuel

4

1 reference

17 December 2017

G Y Gillespie

5

1 reference

17 December 2017

M Y Shao

6

1 reference

17 December 2017

R R Weichselbaum

8

1 reference

17 December 2017

publication date

5 May 2011

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

18

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

1098-1102

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2011.61

exact match

0 references

cites work

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Oncolytic viral therapy of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Inhibition of DNA repair by a herpes simplex virus vector enhances the radiosensitivity of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

ReVOLT: radiation-enhanced viral oncolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Mammalian GADD34, an apoptosis- and DNA damage-inducible gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

The role of salvage reirradiation for malignant gliomas that progress on bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.61

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.61

1 reference

17 December 2017

Dimensions Publication ID

1026234370

0 references

1 reference

17 December 2017